Rapid POC Immunochromatographic Assay Tests for Conjunctivitis

A rapid new point-of-care (POC) immunochromatographic test for conjunctivitis directly detects viral antigens in the eye fluid.

The conjunctivitis test was developed on an assay platform known as direct sampling micro-filtration technology. The technology could be used to develop, manufacture, and market rapid, easy-to-use, POC diagnostic detection tests for infectious diseases and agents, inflammatory conditions, and genetic markers.

The rapid immunochromatographic test called the RPS Adeno Detector offers visual, qualitative in vitro detection of adenoviral antigens (hexon protein) directly from human eye fluid. The test is intended for use as an aid in the rapid differential diagnosis of acute adenoviral conjunctivitis. It is necessary to confirm all negative test results by cell culture.

MinuteClinic (Minneapolis, MN, USA), is a pioneer and operator of in-store health clinics. The company has an agreement with Rapid Pathogen Screening, Inc. (RPS; Sarasota, FL, USA), a biotechnology company, to offer the RPS Adeno Detector test for conjunctivitis, or pink eye. The new point-of-care (POC) test will be initially offered at the MinuteClinics located in 23 CVS pharmacy stores Atlanta (GA, USA).

The partnership is targeting conjunctivitis because it is highly contagious condition that spreads quickly among children in schools or other close environments, such as camps or recreational facilities. The rapid test developed by RPS diagnoses whether the cause is viral or bacterial.

The test will be offered by pharmacies in the Atlanta (GA, USA) area. It is an example of how in-store walk-up clinics might expand their lab testing services.

Related Links:
MinuteClinic
Rapid Pathogen Screening, Inc.